20-10-2021 22:19 via finanzen.net

Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer’s PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in Adults

Pfizer Inc. (NYSE:PFE) announced today that the Centers for Disease Control and Prevention’s...
Weiterlesen »